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Abstract
Background: Although research suggests that socio-sexual behavior changes in conjunction with the menstrual cycle, 
several potential factors are rarely taken into consideration. We investigated the role of changing hormone 
concentrations on self-reported physical discomfort, sleep, exercise and socio-sexual interest in young, healthy 
women.
Methods: Salivary hormones (dehydroepiandrosterone sulfate-DHEAS, progesterone, cortisol, testosterone, estradiol 
and estriol) and socio-sexual variables were measured in 20 women taking oral contraceptives (OC group) and 20 not 
using OCs (control group). Outcome measures were adapted from questionnaires of menstrual cycle-related 
symptoms, physical activity, and interpersonal relations. Testing occurred during menstruation (T1), mid-cycle (T2), and 
during the luteal phase (T3). Changes in behavior were assessed across time points and between groups. Additionally, 
correlations between hormones and socio-behavioral characteristics were determined.
Results: Physical discomfort and sleep disturbances peaked at T1 for both groups. Exercise levels and overall socio-
sexual interest did not change across the menstrual cycle for both groups combined. However, slight mid-cycle 
increases in general and physical attraction were noted among the control group, whereas the OC group experienced 
significantly greater socio-sexual interest across all phases compared to the control group. Associations with hormones 
differed by group and cycle phase. The estrogens were correlated with socio-sexual and physical variables at T1 and T3 
in the control group; whereas progesterone, cortisol, and DHEAS were more closely associated with these variables in 
the OC group across test times. The direction of influence further varies by behavior, group, and time point. Among 
naturally cycling women, higher concentrations of estradiol and estriol are associated with lower attraction scores at T1 
but higher scores at T3. Among OC users, DHEAS and progesterone exhibit opposing relationships with attraction 
scores at T1 and invert at T3.
Conclusions: Data from this study show no change across the cycle in socio-sexual interest among healthy, 
reproductive age women but higher social and physical attraction among OC users. Furthermore, a broader range of 
hormones may be associated with attraction than previously thought. Such relationships differ by use of oral 
contraceptives, and may either reflect endogenous hormone modulation by OCs and/or self-selection of sexually 
active women to practice contraceptive techniques.
Background
A growing body of research addresses the psychological
and behavioral changes women experience across the
menstrual cycle. Much of that research focuses on mood
and sexuality [e.g. [1]]. Subtle shifts in female libido
across the menstrual cycle and somewhat less noticeable
changes in socio-sexual behavior have also been noted
[2,3]. However, comparisons between these types of
effects among normally cycling women and women using
oral contraceptives (OCs) have not been fully investi-
gated. Moreover, the underlying associations between
cyclical and OC-mediated hormone changes and socio-
sexual behavior are not clearly understood.
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In the present paper, we consider the possible role of
changing hormone concentrations on fluctuations in
women's self-reported physical discomfort, sleep, exer-
cise and socio-sexual interest from the functional per-
spective. According to this perspective, behavioral
changes that support favorable mating strategies coincide
with times of high fertility, ovulation, and higher estrogen
concentrations [4]. Conversely, behavioral changes that
promote pregnancy such as decreased sexual and physi-
cal activity and increased sleep are likely to occur during
the luteal or high progesterone phase of the woman's
menstrual cycle. Finally, the observed sleep, activity and
mood disruptions that often develop pre- and peri-men-
strually, in the absence of conception, may be byproducts
of declining hormone levels [5].
A number of projects have supported a functional role
for cyclic socio-sexual behavioral changes [6,7]. Around
the time of ovulation, normally cycling women com-
monly experience increased libido, sexual interest and
attraction towards potential mates [8]. Women report
feeling more attractive themselves, have more interest in
attending events where they might meet men, experience
more mate guarding by their partner [9] and are more
likely to provide a phone number to a prospective mate
during the late follicular/high estrogen phase [10]. Con-
versely, during the luteal phase or high progesterone
phase, women report higher commitment to their rela-
tionships [11]. They also tend to prefer more feminized
male faces which has been postulated to represent a shift
towards a desire for longer term social support [11].
Interestingly, researchers have observed similar rela-
tionships with other hormones. Specifically, female sex-
ual function has been shown to increase during the
ovulatory phase of the menstrual cycle, in congruence
with rising free and total testosterone [12]. This is in
opposition to the work of Battaglia et al. [13], who report
no significant variation in androgens across the cycle but
mention that additional synthesis and metabolism at the
adrenal glands and peripheral tissues make it difficult to
accurately correlate a specific androgen to sexual func-
tion.
Together, these data suggest women's socio-sexual
interests and behaviors fluctuate across the menstrual
cycle, in concert with changes in fertility and circulating
hormone concentrations. How the use of OCs affects
these variable is not clear. Although, OCs have been
reported to attenuate the cyclicity of oxytocin, a pituitary
hormone known to increase during sexual arousal and
orgasm, whereas the influence of oxytocin on lubrication
is maintained despite lacking cyclic variation [14].
Researchers have been otherwise unable to identify con-
sistent patterns in socio-sexual behavior among women
using OCs [10,15-17]. This may reflect the lower concen-
trations and smaller variations in endogenous hormone
concentrations found in women using OCs or reactions
mediated by the synthetic hormones themselves.
Our aims in the present study are to: 1) examine
whether women experience alterations in physical dis-
comfort, sleep quality, exercise, and socio-sexual interest
across the cycle; 2) evaluate whether normally cycling
women experience different patterns in these outcomes
compared with women on OCs; and 3) identify the hor-
monal correlates of these outcomes at different stages in
the cycle, both in normally cycling women and women
using OCs.
Methods
Participants
This research is part of a larger study to gain insight into
the psychological, social, and behavioral aspects of ste-
roid hormones and the menstrual cycle. A full descrip-
tion of other study measures is provided in Guillermo et
al. (in review). Healthy, non-smoking, and regularly
cycling women between the ages of 18-30 were recruited
from the student population at the University of Nevada,
Las Vegas. This study was approved by the University of
Nevada, Las Vegas Institutional Review Board and all
participants voluntarily provided a written, informed
consent prior to enrollment.
Individuals were excluded if they reported diagnosis of
mental illness, endocrine disease, substance abuse, medi-
cation use or medical conditions that would alter hor-
mone concentrations; this includes the use of OCs among
the control group within the last six months of enroll-
ment. Additionally, women were excluded from analysis
if they had irregular cycles, as classified by having less
than 25 or greater than 40 days and deviating more than
10 days from self-reported average cycle length. Fifty-six
women enrolled in the study; however, nine were lost to
attrition and seven were excluded due to irregular men-
strual cycles. As a result, twenty normally cycling women
were assigned to the control group and twenty women
using oral contraceptives were assigned to the OC group.
Physical discomfort, sleep disturbance, exercise levels,
socio-sexual interests, and hormone values were assessed
three times during the course of a single menstrual cycle:
early- to mid-follicular phase (T1), mid-cycle (T2), and
the mid- to late-luteal phase (T3) corresponding to
roughly days 7, 14, and 21 for a 28-day cycle. Specimen
collection days and subsequent test times were deter-
mined based on individually reported average menstrual
cycle length and adjusted for the start date of the next
menses after the enrollment interview.
Outcome Measures
At each session, a questionnaire was administered to
measure change in behavior across the menstrual cycle.
The questionnaire was derived from sections of severalGuillermo et al. BMC Women's Health 2010, 10:19
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social behavior and attraction questionnaires that
included questions regarding physical activity (Interna-
tional Physical Activity Questionnaire; "IPAQ", 2002),
sleep patterns (Karolinska Sleep Questionnaire) [17,18],
and interpersonal relations (Interpersonal Attraction
Scales) [19,20]. Questions regarding menstrual cycle
related physical discomfort (cramping, bloating, breast
tenderness, etc.) were derived from Premenstrual Symp-
tom Daily Rating Scale [21,22]. A question of general
physical activity was included, in which the women were
asked about the average amount of vigorous physical
activity (minutes/hours per day) over the last three days.
Questions rating general attraction, as well as social,
physical/sexual, and task-oriented attraction, towards a
current or potential significant other were also asked. All
questions utilized a 5-point Likert-type scale (i.e. 0 = "not
at all" to 4 = extremely). For the purposes of data analyses,
questions were categorized by content and analyzed by
category. Individual questions and categories are listed in
Table 1.
Hormone collection procedures
Pre-prandial, morning salivary specimens were collected
via expectoration prior to arrival at the testing facility.
Hormone specimens were stored in a -25°C freezer until
batch analyses by a commercial, CLIA certified labora-
tory (ZRT Laboratory; Beaverton, OR) using indirect
enzyme-linked immunosorbent assay (ELISA) tech-
niques. All hormone testing supplies and analyses were
provided and conducted by ZRT Laboratory. Inter- and
intra assay coefficients of variation did not exceed 15% for
any analyte.
Statistical Analysis
Category scores were based upon the summed scores of
individual questions within each category. Attraction
questions that reflected a negative interaction with a cur-
rent or potential significant other were reverse-scaled to
maintain consistency in analysis. Within-cycle and
between-group differences were calculated using a
mixed-model analysis of variance (ANOVA). Assump-
tions of sphericity for each variable were evaluated using
Mauchly's W statistic. If sphericity was violated, adjust-
ments to the significance levels were made using the
Greenhouse-Geisser method. All analyses were calcu-
lated using the statistical software SPSS 16.0 and PASW
17.0 (formerly SPSS).
Between-group comparisons of demographic features
were assessed through Student's t-test. Between-group
comparisons of physical discomfort, sleep, exercise and
socio-sexual categories were calculated using a series of
one-way ANOVAs for each category and by time point.
Associations between hormones and outcome variables
were calculated using Pearson Product Moment Correla-
tions. Normality was assessed and non-normally distrib-
uted values were log10-transformed prior to analysis to
meet the normality assumptions of the test. Only testos-
terone was normally distributed and did not require
transformation. Correlations for estriol, which could not
Table 1: Description and list of individual questionnaire 
items for each socio-behavioral category.
Behavior
Physical Discomfort (0 = lowest frequency, duration, severity; 4 = 
highest frequency, duration, severity)
Cramps and/or abdominal pain
Bloating and/or weight gain
Breast tenderness and swelling
Exercise (hours per day)
Participate in vigorous physical activity as part of work, 
school, home, or leisure time
Sleep Disturbance (0 = statement does not apply at all; 4 = 
statement always applies)
Experience repeated awakenings
Feel exhausted upon waking
Do not feel well-rested after sleeping
Fight falling asleep during the day
Fall asleep at work, school, or activities
General Attraction (0 = not at all; 4 = extremely)
Feel an attraction or interest toward another person
Social Attraction
Would be difficult to approach other (reverse-scaled)
Would not be able to establish a friendly rapport with other 
(reverse-scaled)
Other would understand how I feel
Would enjoy the company of other
Physical Attraction
Would find other physically attractive
Other would be sexually appealing
Would take pleasure in sexual relations with other
Task-oriented Attraction
Would not get anything accomplished with other (reverse-
scaled)
Would be able to depend on other to get things done
Other would be fun to work withGuillermo et al. BMC Women's Health 2010, 10:19
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be normalized by transformation, were calculated using
Spearman's Rho. Post-hoc correlations between individ-
ual questions and hormone concentrations were calcu-
lated to evaluate more fully the trends in socio-sexual
interest.
Results
Participant characteristics
Table 2 summarizes the demographic data by group.
Mean test days were T1 = 5.78 (SD 2.09), T2 = 14.25 (SD
1.77), T3 = 22.50 (SD 2.34) for all groups combined. No
differences were found between age, education or body
mass index (BMI), whereas a higher proportion of Asian/
Pacific Islanders were in the control group in comparison
to the OC group. Although the distribution of BMI was
not statistically significant, more overweight (25 < BMI <
30) women were naturally cycling (control n = 5; OC n =
2) and more obese (BMI > 30) women were OC users
(control n = 1; OC n = 4).
Hormone preparations varied greatly, thus preventing
any post-hoc analysis with sufficient statistical power. Of
the twenty OC users' pill regimens, 8 were low-estrogen
(20-25 μg) versus high-estrogen (30-35 μg) and 5 were
multiphasic versus monophasic. Among the different
progestin components, 5 women were using OCs con-
taining drospirenone, 5 norgestimate, 4 levonorgestrel, 4
norethindrone, 1 desogestrel, and 1 norgestrel.
Alterations in physical discomfort, exercise, sleep 
disturbance, and socio-sexual interest across the cycle
As illustrated in Table 3, participants experienced a sig-
nificantly greater physical discomfort and more disturbed
sleep during the follicular phase as compared to any other
phase of the menstrual cycle. No cycle-related changes
were observed in exercise, or the general, social, and task
attraction scales.
Between-group differences in physical discomfort, 
exercise, sleep disturbance, and socio-sexual behavior
Results of between-group analyses are presented in Table
4. No between-group differences in physical discomfort,
exercise or sleep were observed. At each phase of the
menstrual cycle, women taking an OC reported signifi-
cantly higher general attraction toward current or poten-
tial mates, significantly higher social attraction across all
phases and higher physical attraction, particularly during
the follicular phase, compared to the control group. No
differences were found in task attraction.
Hormonal correlations with physical discomfort, exercise, 
sleep disturbance, and socio-sexual perceptions
As illustrated by Table 5, relationships between individual
hormones and the variables measured differed by group
and by cycle phase. For the control group, higher estra-
diol was associated with more physical discomfort at T1
and more perceptions of physical attraction at T3. Higher
estriol, however, was associated with less general attrac-
tion at T3. None of the other hormones measured were
associated with any other variables.
This is in contrast to the OC group where a broader
range of hormones was associated with a number of indi-
vidual indices. For this group, DHEAS was positively
associated with general attraction during the follicular
phase and exercise levels at mid-cycle and the luteal
Table 2: Descriptive statistics of demographic data by group (frequency and proportion or mean and SD, as appropriate).
Characteristic Control Group OC Group T-Test
Age 20.3 (2.56) 20.5 (1.79) n.s.
Education (yrs) 14.8 (1.68) 15.4 (1.93) n.s.
BMI 23.3 (3.85) 24.3 (4.50) n.s.
Cycle length 30.5 (4.12) 27.6 (1.29) t = 2.99, p < 0.01
Test Day
Follicular 5.6 (2.24) 6.0 (1.97) n.s.
Mid-Cycle 14.5 (2.21) 14.0 (1.17) n.s.
Luteal 22.8 (3.00) 22.2 (1.44) n.s.
Race/Ethnicity
Caucasian/NHW 8 (40%) 11 (55%)
African American/Black 1 (5%) 1 (5%)
Hispanic/Latino 5 (25%) 5 (25%)
Asian/Pacific Islander 6 (30%) 3 (15%)
Education based on years from kindergarten through college; BMI: Body Mass Index; NHW: Non-Hispanic White.Guillermo et al. BMC Women's Health 2010, 10:19
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phase. Follicular estriol concentrations were inversely
associated with physical attraction. During the luteal
phase, higher estradiol, progesterone, testosterone and
DHEAS concentrations were associated with more exer-
cise while cortisol was correlated negatively with physical
discomfort.
In an effort to fully understand the role of hormones in
socio-sexual behavior, correlations between the individ-
ual questions and hormones were calculated (Table 5).
Due to the number of correlations, these data should be
regarded as trends. Nevertheless, they provide important
clues regarding the pattern of hormone-to-behavior rela-
tionships in normally cycling and OC-using women. As
the table illustrates, associations between hormones and
socio-sexual questions, with the exception of progester-
one, were negative for both groups during the follicular
phase. At mid-cycle, higher cortisol was associated with
"enjoying the company of the other" for the control
group, whereas higher estradiol and DHEAS concentra-
tions were linked positively to task attraction in the OC
group. During the luteal phase, higher estradiol and est-
riol were associated with sexual interest questions in the
control group, whereas higher progesterone was associ-
ated with more social attraction and better work interac-
tions in the OC group. In addition, higher luteal DHEAS
meant lower social and physical attraction for the OC
group.
Discussion
The monthly window of human female fertility is very
short. Functionally, natural selection should favor female
behaviors that increase the odds of successful mating
around the time of ovulation [4] and preserve the preg-
nancy, post-conception. We expected 1) each of these
r e p r o d u c t i v e  p h a s e s  t o  b e  a s s o c i a t e d  w i t h  c h a n g e s  i n
activity levels and socio-sexual interest, 2) these changes
would be mediated by fluctuations in endogenous hor-
mones, and 3) to the extent that OCs altered the natural
reproductive cycle, we expected behavioral differences
between naturally cycling women and those using OCs.
Results from this study revealed that physical discomfort,
sleep and sexual interest vary by cycle-phase, but do not
Table 3: Comparison of socio-behavioral categories (max possible scores) by phase in menstrual cycle.
Behavior Statistic Follicular Mid-Cycle Luteal Main Effect T1 vs. T2 T2 vs. T3
Physical Discomfort (36) Mean 13.83 2.55 3.45 46.19*** 68.09*** 0.79
SD 8.81 5.35 6.99
Range 0-33 0-27 0-33
Exercise (hr/day) Mean 1.21 0.74 1.09 1.94
SD 1.94 0.75 1.47
Range 0-8 0-2 0-5
Sleep Disturbance (20) Mean 8.40 4.90 4.68 25.22*** 38.82*** 0.24
SD 4.06 3.83 4.26
Range 1-18 0-16 0-19
General Attraction (4) Mean 2.05 2.28 2.00 1.12
SD 1.43 1.20 1.16
Range 0-4 0-4 0-4
Social Attraction (16) Mean 12.28 12.33 12.65 0.41
SD 3.05 2.95 2.46
Range 5-16 2-16 7-16
Physical Attraction (12) Mean 8.45 8.73 8.05 0.96
SD 3.29 3.48 3.89
Range 2-12 0-12 0-12
Task-oriented 
Attraction (12)
Mean 7.90 8.00 8.00 0.05
SD 2.32 2.72 2.66
Range 2-12 1-12 1-12
*p < .05, **p < .01, ***p < .001.
T1: early- to mid-follicular phase, T2: mid-cycle, T3: mid- to late-luteal phase.Guillermo et al. BMC Women's Health 2010, 10:19
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Table 4: Socio-behavioral categories (max possible scores) by group and between-group comparisons.
Behavior Time Control Group OC Group Between-Group
Mean SD Range Mean SD Range F-value p-value
Physical Discomfort (36) Follicular 13.85 10.36 0-33 13.80 7.19 3-29 0.08 0.78
Mid-Cycle 2.35 6.34 0-27 2.75 4.29 0-13
Luteal 2.90 7.85 0-33 4.00 6.16 0-20
Exercise (hr/day) Follicular 0.83 1.23 0-4 1.60 2.43 0-8 2.09 0.16
Mid-Cycle 0.63 0.65 0-2 0.85 0.84 0-2
Luteal 0.80 1.11 0-4 1.38 1.74 0-5
Sleep Disturbance (20) Follicular 9.20 4.56 1-18 7.60 3.42 2-13 2.58 0.12
Mid-Cycle 5.60 4.39 0-16 4.20 3.12 0-13
Luteal 5.75 5.07 0-19 3.60 3.02 0-9
General Attraction (4) Follicular 1.50 1.24 0-4 2.60 1.43 0-4 18.15 <0.001
Mid-Cycle 1.78 1.15 0-4 2.79 1.06 0-4
Luteal 1.31 0.96 0-3 2.68 0.92 1-4
Social Attraction (16) Follicular 11.15 3.28 5-16 13.40 2.39 9-16 7.92 <0.01
Mid-Cycle 11.25 3.49 2-16 13.40 1.79 8-16
Luteal 12.00 2.43 8-16 13.30 2.36 7-16
Physical Attraction (12) Follicular 6.95 3.44 2-12 9.95 2.37 4-12 5.83 0.02
Mid-Cycle 7.95 3.79 1-12 9.50 3.03 0-12
Luteal 7.00 4.36 0-12 9.10 3.11 0-12
Task-oriented Attraction (12) Follicular 7.50 2.37 2-10 8.30 2.25 3-12 1.83 0.18
Mid-Cycle 7.35 2.92 1-12 8.65 2.39 4-12
Luteal 7.65 2.92 1-11 8.35 2.68 3-12
appear to influence socio-sexual interest and that OC use
and endogenous hormones affect socio-sexual interest,
but not in the manner proposed by the functional per-
spective.
As expected, physical discomfort was significantly
more prominent during the follicular phase of the cycle.
Moreover, these data are consistent with most other stud-
ies finding no general patterns between exercise and cycle
phase [23]. Interestingly however, there were no differ-
ences in discomfort levels between the two groups of
women at any cycle phase. During the follicular phase,
estradiol concentrations were significantly associated
with discomfort in the control group, but no hormone
associations were observed for the OC group. However,
during the luteal phase, lower cortisol and progesterone
concentrations contributed to more discomfort in the OC
group.
In addition to increased physical discomfort during the
follicular phase, strong cycle- but not group-related sleep
differences were observed. During the follicular phase,
both groups reported more sleep disturbances compared
to the other phases. Although existing research investi-
gating cycle-related shifts in sleep is sparse, some have
observed reductions in REM sleep [24] or poorer sleep
[23] during the luteal phase and increases in sleep distur-
bances in the days prior to and during menses. Research-
ers postulate that higher luteal phase estradiol
concentrations precede both increased physical discom-
fort and disturbed sleep [25]. Despite a lack of association
between combined sleep disturbance scores and hor-
mones, we observed positive correlations for individual
questions with estradiol and estriol among the control
group during T3 and T1, respectively, and a negative cor-
relation with testosterone among the OC group during
T2 (Table 5).
Consistent with a functional perspective, physical
attraction trended upward at mid-cycle for normally
cycling women [26,27]. This was not the case for women
in the OC group, where physical attraction levels were
consistently higher across the cycle and significantly ele-
vated compared to the control group. The OC group also
scored significantly higher on measures of general andGuillermo et al. BMC Women's Health 2010, 10:19
http://www.biomedcentral.com/1472-6874/10/19
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Table 5: Correlations of hormones to socio-behavioral categories and individual questionnaire items.
Control Group OC Group
T1 Physical Discomfort E2 .500* T1 General Attraction D .450*
Cramp Frequency E2 .453* Physical Attraction E3 -.488*
Bloating Severity E2 .658** Physically Attracted E3 -.544*
Bloating Frequency E3 .447* Physically Attracted T -.543*
Bloating Severity T .526* Task-Oriented Attraction n.s.
Exercise E2 .575** Depend on Other P -.456*
Sleep Disturbance n.s. Depend on Other T -.558*
Awakenings E3 .481* T2 Physical Discomfort n.s.
Social Attraction T -.541* Bloating Duration E3 .543*
Approach Other E2 -.662** Bloating Severity E3 .543*
Establish Rapport E2 -.456* Bloating Frequency D .455*
Approach Other E3 -.497* Exercise D .496*
Approach Other T -.646** Sleep Disturbance n.s.
Establish Rapport T -.544* Fight Falling Asleep T -.456*
Physical Attraction n.s. Social Attraction n.s.
Physically Attracted P .472* Approach Other D .535*
T2 Physical Discomfort n.s. Task-Oriented Attraction n.s.
Bloating Duration E3 .543* Accomplish Work with Other E2 .465*
Bloating Severity E3 .543* Accomplish Work with Other E3 .452*
Bloating Frequency D .455* Accomplish Work with Other D .623**
Social Attraction n.s. T3 Physical Discomfort C -.482*
Enjoy Company C .487* Breast Tenderness Duration P -.454*
T3 Sleep Disturbance n.s. Breast Tenderness Severity P -.470*
Awakenings E2 .466* Cramp Duration C -.525*
General Attraction E3 -.462* Breast Tenderness Frequency C -.483*
Social Attraction n.s. Breast Tenderness Duration C -.479*
Understood by Other E2 .474* Exercise E2 .594**
Physical Attraction E2 .446* Exercise P .461*
Other Sexually Appealing E2 .486* Exercise T .572**
Task-oriented Attraction Exercise D .465*
Accomplish Work with Other E3 .564** Social Attraction n.s.
Establish Rapport P .556*
Understood by Other D -.466*
Physical Attraction n.s.
Physically Attracted D -.446*
Task-Oriented Attraction n.s.
Accomplish Work with Other P .507*
*p < 0.05, **p < 0.01, n.s. = non-significant for category associations.
T1: early- to mid-follicular phase, T2: mid-cycle, T3: mid- to late-luteal phase;, E2: estradiol, P: progesterone, E3: estriol, T: testosterone, D: 
dehydroepiandrosterone sulfate, C: cortisol.Guillermo et al. BMC Women's Health 2010, 10:19
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social attraction across all phases of the cycle compared
to the control group and exhibited a distinctly different
hormone profile relative to these variables.
In contrast to the functional perspective, mid-cycle
estradiol was not associated with sexual or social interest,
but it was associated with these variables during the
luteal phase in the control group. Similarly, progesterone,
which per the functional perspective was expected to be
negatively associated with luteal phase socio-sexual inter-
est and potentially associated with follicular phase sleep
disturbances or physical discomfort, was not correlated
with any of these variables in normally cycling women.
These findings, though inconsistent with the functional
perspective, are partially in-line with the physiological
and endocrine investigations of female sexual arousal.
Despite methodological differences among studies of
female sexual behavior, several consistent trends emerge.
Firstly, sexual activity (e.g. intercourse or masturbation),
arousal (vaginal constriction and lubrication) and subjec-
tive sexual interest should be considered as separate,
albeit interacting, variables with potentially different
endocrine mediators. When these variables are dissoci-
ated, the data somewhat consistently point to a decrease
in sexual activity, but not necessarily sexual interest, dur-
ing the early follicular phase, with a trend towards
increased mid-cycle sexual interests [15,26,28] that may
or may not correspond to actual changes in sexual activ-
ity. Our data support these trends.
Secondly, both androgens and estrogens play an impor-
tant role in female sexual arousal, motivation, and activity
[12,15]. In most cases, increased androgens such as dehy-
droepiandrosterone (DHEA), dehydroepiandrosterone
sulfate (DHEAS), androstenedione and/or testosterone
favor sexual arousal [29-32], but this relationship may be
age, concentration and cycle-phase dependent. Mid-cycle
testosterone tends to increase sexual arousal, whereas
during the follicular and luteal phases this trend is
reversed [33,34]. In contrast, higher progesterone and
estradiol concentrations are associated with lower sexual
interest, but may also be, age, concentration and cycle-
phase dependent [12,34]. To our knowledge, neither cor-
tisol nor estriol have been investigated in association with
female social or sexual interest across the menstrual
cycle.
In the present study, women using OCs reported signif-
icantly higher social and sexual interest across all test
times, with no significant fluctuations related to cycle-
phase. The lack of cycle-related changes in sexual interest
may be related to suppression or leveling of endogenous
hormones by their synthetic counterparts [14,28] or may
simply be a matter of self-selection to this particular
group, in that women in the OC group were likely more
often involved in sexual relationships than women in the
control group. Some evidence suggest a small minority of
women using OCs report diminished sexual interest
[28,35-37], whereas other research shows no change [38]
or increased interest and activity [39,40]. The effects of
oral contraceptives on sexual arousal and activity are not
well understood and likely depend as much upon individ-
ual hormonal and socio-sexual parameters as on the type
and dosage of the synthetic steroids administered.
Similar to the control group, hormone-to-socio-sexual
behavior relationships in the OC group were complex
and multi-directional. With DHEAS as the exception,
negative associations between hormones and socio-sex-
ual variables were observed both at T1 and at T3, whereas
positive associations were observed at mid-cycle. In con-
trast to the control group, however, DHEAS and proges-
terone played a more prominent role in socio-sexual
interest. The altered influence of progesterone is not
unexpected as results showed that women in the OC
group had significantly lower progesterone than the con-
trol group at both T2 and T3 (Guillermo et al., in review).
Moreover, although our study did not show any signifi-
cant differences in DHEAS between controls and OC
users at any time point, others have shown that women
who use OCs have lower DHEAS than non-users [41].
Hence, both DHEAS and progesterone may exert more
influence at lower levels.
Unfortunately , a larger sample is necessary to resolve
such complex interactions in a manner that is both mean-
ingful and valid. Although the sample size of 20 women in
each of the cycling and OC groups is modest, it is compa-
rable to those employed in similar types of study designs.
Additionally, this study is subject to further limitations.
The women were young and healthy and thus, their expe-
riences may not generalize to older populations of
women. That said, a younger sample may provide more
accurate results among women with normal sexual func-
tion.
Study duration was approximately one hour for each
test session; thus, no assessments were given to confirm
participant mental health status, sexual preference, sexual
function and activity, or average cycle length. Although
participants were not asked whether they engaged in het-
erosexual, homosexual, or bisexual relationships,
research has shown that individuals in homosexual rela-
t i o n s h i p s  r e p o r t  h i g h e r  s e x u a l  d e s i r e  a s  c o m p a r e d  t o
those in heterosexual relationships [42]. Additionally, the
compiled questionnaire has not been previously validated
with a sufficient sample. Hence, although the outcome
measures appear to have tapped some of the desired out-
comes, findings are vulnerable to inherent problems with
self-reported data and may not be sufficiently sensitive to
detect what could be subtle changes in, not only female
socio-sexual interest, but also sexual functioning.
Despite these limitations, data from the present study
provide a rare opportunity to evaluate variations inGuillermo et al. BMC Women's Health 2010, 10:19
http://www.biomedcentral.com/1472-6874/10/19
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female socio-sexual interest across the menstrual cycle in
both naturally cycling women and those who utilize oral
contraceptives in correspondence with endogenous hor-
mones, sleep, physical discomfort, and activity levels.
These data show a mid-cycle increase in sexual interest
for normally cycling women and thus, partially support
the functional perspective of female mating behavior.
Moreover, OC users experienced higher overall social
and physical attraction. However, our results do not sup-
port the postulated roles for estradiol and progesterone
on socio-sexual behavior in normally cycling women.
Conclusions
Cycle-related changes in sleep, activity and physical dis-
comfort do not appear to have much bearing on socio-
sexual interest, nor do such behaviors differ with oral
contraceptive use. However, attraction did appear to dif-
fer with OC usage. Findings from this study add to the
current body of knowledge, by demonstrating that 1) a
broader range of hormones is involved in female socio-
sexual interest than is currently investigated, 2) women
who utilize OCs report consistently more interest in
social and sexual endeavors compared to their naturally
cycling counterparts, and 3) socio-sexual interest in
women using OCs may be modulated by different under-
lying hormonal patterns.
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